课题基金 / 基金详情

Improving the efficacy of pressurized metered dose inhaler spacers

Improving the efficacy of pressurized metered dose inhaler spacers
提高加压定量吸入器储雾器的功效
批准号:
472717-2014
负责人:
Arzanpour, Siamak
金额:
$0.7万
依托单位:
依托单位国家:
加拿大
项目类别:
Collaborative Research and Development Grants
财政年份:
2018
资助国家:
加拿大
项目状态:
已结题
起止时间:
2018-01-01 至 2019-12-31

项目摘要

项目成果

Arzanpour, Siamak的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Pressurized Metered Dose Inhalers (pMDIs) are devices used to deliver a specific amount of medication to the lungs but require perfect timing of activation and inhalation for the best efficacy. A spacer is a medical device which sits between pMDI canister and the oral cavity and allows longer drug suspension and more time for patients to slowly and deeply inhale the medication. The goal of this NSERC CRD proposal is to design the next generation of inhaler spacers to improve efficacy of drug delivery (less deposition on the spacers) and patients' convenience (extended inhalation time). The project will focus on the development of two innovative actuated pMDI spacers, the Vibrochamber and Turbochamber. First, an accurate finite element model of the drug delivery process in spacers will be developed and experimentally verified. This model will then be used for numerical simulations and optimization of the actuated spacers. Finally, prototypes of the spacers will be fabricated and tested in a standard experimental setup.**This CRD project is in partnership with Pacificure Biomedical Inc., which has been active in the development and manufacturing of medical devices including pMDI spacers. Dr. Arzanpour from the School of Mechatronic Systems Engineering (MSE) at Simon Fraser University (SFU) will lead the research team. A strong collaborative approach between SFU and Pacificure was established during an NSERC Engage project with outstanding outcomes. New knowledge relating to numerical simulation of particle flow will be generated. In addition to the economic benefits to the company and Canada, this project will help Canadians who suffer from respiratory diseases, including 2.5 million asthma patients and 1.8 million chronic obstructive pulmonary disease (COPD) patients. Improving the efficacy of drug delivery in spacers will help patients to use the drug more effectively and prevents side effects cause by deposition of the drug in oral cavity. Moreover, this project is planned to train three HQP including one PhD and two co-op students in a variety of disciplines and skills which are highly marketable for academic positions as well as a wide range of industries.**********************
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Next Generation of Efficient and Responsive Vibration Energy Harvesters
  • 批准号:
    RGPIN-2022-05279
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $1.97万
  • 财政年份:
    2022
  • 负责人:
    Arzanpour, Siamak
  • 依托单位:
Next Generation of Intelligent Anthropomorphic Exoskeleton Systems
  • 批准号:
    RGPIN-2019-06600
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.33万
  • 财政年份:
    2019
  • 负责人:
    Arzanpour, Siamak
  • 依托单位:
Next Generation Small Intelligent Machining Systems
  • 批准号:
    RGPIN-2014-04526
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $1.75万
  • 财政年份:
    2018
  • 负责人:
    Arzanpour, Siamak
  • 依托单位:
Improving the efficacy of pressurized metered dose inhaler spacers
  • 批准号:
    472717-2014
  • 项目类别:
    Collaborative Research and Development Grants
  • 资助金额:
    $0.7万
  • 财政年份:
    2017
  • 负责人:
    Arzanpour, Siamak
  • 依托单位:
国内基金
海外基金
噬菌体靶向肠道粪肠球菌提高帕金森病左旋多巴疗效的机制研究
  • 批准号:
    82371251
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    肖勤
  • 依托单位:
新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
  • 批准号:
    82370885
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    姚晨
  • 依托单位:
HER2特异性双抗原表位识别诊疗一体化探针研制与临床前诊疗效能研究
  • 批准号:
    82372014
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    魏伟军
  • 依托单位: